SELECT MEDICAL HOLDINGS CORP (SEM) Stock Fundamental Analysis

NYSE:SEM • US81619Q1058

16.38 USD
+0.09 (+0.55%)
At close: Feb 13, 2026
16.38 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

SEM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. SEM has a medium profitability rating, but doesn't score so well on its financial health evaluation. SEM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SEM was profitable.
  • In the past year SEM had a positive cash flow from operations.
  • In the past 5 years SEM has always been profitable.
  • In the past 5 years SEM always reported a positive cash flow from operatings.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • With a decent Return On Assets value of 3.72%, SEM is doing good in the industry, outperforming 68.63% of the companies in the same industry.
  • With a decent Return On Equity value of 12.53%, SEM is doing good in the industry, outperforming 78.43% of the companies in the same industry.
  • SEM has a Return On Invested Capital of 4.34%. This is comparable to the rest of the industry: SEM outperforms 50.98% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SEM is significantly below the industry average of 9.04%.
  • The last Return On Invested Capital (4.34%) for SEM is above the 3 year average (3.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROIC 4.34%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • SEM has a better Profit Margin (4.08%) than 75.49% of its industry peers.
  • SEM's Profit Margin has improved in the last couple of years.
  • With a decent Operating Margin value of 5.17%, SEM is doing good in the industry, outperforming 64.71% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SEM has declined.
  • Looking at the Gross Margin, with a value of 12.22%, SEM is doing worse than 70.59% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SEM has declined.
Industry RankSector Rank
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SEM is destroying value.
  • SEM has more shares outstanding than it did 1 year ago.
  • SEM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SEM has been reduced compared to a year ago.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 1.59, we must say that SEM is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of SEM (1.59) is comparable to the rest of the industry.
  • The Debt to FCF ratio of SEM is 10.18, which is on the high side as it means it would take SEM, 10.18 years of fcf income to pay off all of its debts.
  • SEM has a Debt to FCF ratio (10.18) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that SEM has dependencies on debt financing.
  • SEM's Debt to Equity ratio of 1.03 is on the low side compared to the rest of the industry. SEM is outperformed by 62.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Altman-Z 1.59
ROIC/WACC0.44
WACC9.86%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • SEM has a Current Ratio of 1.09. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SEM (1.09) is worse than 64.71% of its industry peers.
  • SEM has a Quick Ratio of 1.09. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of SEM (1.09) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • SEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.81%.
  • The Earnings Per Share has been growing slightly by 5.88% on average over the past years.
  • SEM shows a small growth in Revenue. In the last year, the Revenue has grown by 7.48%.
  • Measured over the past years, SEM shows a decrease in Revenue. The Revenue has been decreasing by -1.00% on average per year.
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.83% on average over the next years.
  • SEM is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.85% yearly.
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.05 indicates a rather expensive valuation of SEM.
  • Based on the Price/Earnings ratio, SEM is valued a bit cheaper than 76.47% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.97, SEM is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 12.37 indicates a correct valuation of SEM.
  • SEM's Price/Forward Earnings ratio is rather cheap when compared to the industry. SEM is cheaper than 85.29% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.96. SEM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 19.05
Fwd PE 12.37
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 76.47% of the companies in the same industry are more expensive than SEM, based on the Enterprise Value to EBITDA ratio.
  • 80.39% of the companies in the same industry are more expensive than SEM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.65
EV/EBITDA 8.92
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of SEM may justify a higher PE ratio.
  • A cheap valuation may be justified as SEM's earnings are expected to decrease with -2.53% in the coming years.
PEG (NY)N/A
PEG (5Y)3.24
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • SEM has a Yearly Dividend Yield of 1.53%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.48, SEM pays a better dividend. On top of this SEM pays more dividend than 89.22% of the companies listed in the same industry.
  • SEM's Dividend Yield is comparable with the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 1.53%

5.2 History

  • SEM has paid a dividend for at least 10 years, which is a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 18.80% of the earnings are spent on dividend by SEM. This is a low number and sustainable payout ratio.
DP18.8%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (2/13/2026, 8:04:00 PM)

After market: 16.38 0 (0%)

16.38

+0.09 (+0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners82.91%
Inst Owner Change-2.73%
Ins Owners11.06%
Ins Owner Change0.26%
Market Cap2.03B
Revenue(TTM)5.19B
Net Income(TTM)211.72M
Analysts77.78
Price Target18.53 (13.13%)
Short Float %4.23%
Short Ratio4.71
Dividend
Industry RankSector Rank
Dividend Yield 1.53%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP18.8%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.01%
Min EPS beat(2)30.21%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)-20.63%
Min EPS beat(4)-158.51%
Max EPS beat(4)49.82%
EPS beat(8)4
Avg EPS beat(8)-7.1%
EPS beat(12)7
Avg EPS beat(12)-2.62%
EPS beat(16)9
Avg EPS beat(16)-3.49%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-3.63%
Min Revenue beat(4)-11.07%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.53%
Revenue beat(12)7
Avg Revenue beat(12)-0.91%
Revenue beat(16)10
Avg Revenue beat(16)5.68%
PT rev (1m)0%
PT rev (3m)0.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)3.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 19.05
Fwd PE 12.37
P/S 0.39
P/FCF 11.65
P/OCF 4.98
P/B 1.2
P/tB N/A
EV/EBITDA 8.92
EPS(TTM)0.86
EY5.25%
EPS(NY)1.32
Fwd EY8.08%
FCF(TTM)1.41
FCFY8.58%
OCF(TTM)3.29
OCFY20.1%
SpS41.89
BVpS13.64
TBVpS-6.02
PEG (NY)N/A
PEG (5Y)3.24
Graham Number16.25
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROCE 5.65%
ROIC 4.34%
ROICexc 4.39%
ROICexgc 9.14%
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
FCFM 3.35%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
ROICexc(3y)3.14%
ROICexc(5y)4.99%
ROICexgc(3y)6.3%
ROICexgc(5y)12.6%
ROCE(3y)4.06%
ROCE(5y)6.32%
ROICexgc growth 3Y-27.06%
ROICexgc growth 5Y-9.65%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-5.51%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
F-Score5
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Debt/EBITDA 4.17
Cap/Depr 155.87%
Cap/Sales 4.5%
Interest Coverage 2.17
Cash Conversion 97.47%
Profit Quality 82.19%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.59
F-Score5
WACC9.86%
ROIC/WACC0.44
Cap/Depr(3y)103.75%
Cap/Depr(5y)94.3%
Cap/Sales(3y)4.39%
Cap/Sales(5y)3.74%
Profit Quality(3y)115.02%
Profit Quality(5y)150.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A
EBIT growth 1Y0.4%
EBIT growth 3Y-27.83%
EBIT growth 5Y-10.68%
EBIT Next Year-15.98%
EBIT Next 3Y-1.14%
EBIT Next 5YN/A
FCF growth 1Y-9.04%
FCF growth 3Y10.24%
FCF growth 5Y0.52%
OCF growth 1Y-1.83%
OCF growth 3Y8.88%
OCF growth 5Y3.07%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 6 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 19.05 and the Price/Book (PB) ratio is 1.2.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.